About The Cary Council
In September 2015, Southwestern Medical Foundation and UT Southwestern launched The Cary Council, a group of emerging community leaders, whose mission is to support and strengthen the work of the Medical Center and Foundation. The Council was created to educate the next generation about the critical role medical research, education, and patient care plays in improving our health and making Dallas a world-class city.
Since its founding, The Cary Council has been dedicated to carrying on Dr. Edward H. Cary’s legacy to “inspire a great citizenship to greater deeds.”
We are delighted to announce our inaugural event: An Evening with DocStars, in the beautiful C. Vincent Prothro Plaza and Garden at UT Southwestern. This will be The Cary Council’s signature fundraiser. We hope you will plan to attend an exciting evening under the stars, featuring live music, outstanding food, and thrilling opportunities to see medicine in action through interactive booths featuring simulated technologies and DocStars in action. Watch this video for a preview of some of the simulated technologies that will be at the event.
Funds raised from this event will support young UT Southwestern investigators working on promising early stage research. Philanthropy is vital in advancing early-stage research which may be too nascent to qualify for other funding sources. Finalists will be chosen by UT Southwestern faculty and the recipient(s) will be selected by The Cary Council.
E V E N T C O – C H A I R S : Lana Constantine Amanda Eagle George
C H A I R M A N : Michael Kahn
Thank You to Our Sponsors
N O B E L L A U R E A T E – L E A D E V E N T S P O N S O R Highland Capital Management/Nexbank
D I S T I N G U I S H E D C H A I R – E N T E R T A I N M E N T S P O N S O R The Adair Foundation
H O W A R D H U G H E S I N V E S T I G A T O R – R E C E P T I O N S P O N S O R Sewell Automotive Companies
F E L L O W L E V E L Goldman Sachs
M. D. S P O N S O R L E V E L Fluor Corporation Lyda Hill The Beth F. Kahn Roots and Wings Fund Trinity Industries
R E S I D E N T – V A L E T S P O N S O R John Eagle Dealerships
I N T E R N – B O O T H S P O N S O R S Campbell Foundation Dr. Sami Constantine and Dr. Fadi Constantine Gay and Bill Solomon Thompson & Knight Foundation
M E D I C A L S T U D E N T – P R I N T I N G S P O N S O R S The Eugene McDermott Foundation NCH Corporation Mike and Mary Terry
D O N A T I O N S Kathy and Gene Bishop Grace Cook Berry R. Cox Family Foundation The Ifill Family Sarah and Alan Losinger Lizzie and Dan Routman
I N K I N D S P O N S O R JK Chocolate Harris Polakoff
M E D I A S P O N S O R
Eight finalists were recommended by Greg Fitz, M.D., UT Southwestern Medical School’s Provost and Dean, and David Russell, Ph.D., Vice Provost and Dean of Basic Research, and Dean. The Cary Council Steering Committee voted on the top three finalists.
Richard C. Wang, M.D., Ph.D.
Helping solve the beginnings of skin tumors
Dr. Wang received his B.S. from Stanford University. He then enrolled in the Tri-Institutional M.D./Ph.D. Program in New York. He completed his graduate work with Dr. Titia de Lange at The Rockefeller University.
After receiving his M.D. from Cornell in 2006, he returned to Texas to complete his internship in internal medicine and residency in dermatology at UT Southwestern. He received support from the UTSW Physician Scientist Training Program and the Dermatology Foundation to do a research fellowship with Dr. Beth Levine.
His research focuses on pathways central to both the development of normal skin and non-melanoma skin cancer tumorigenesis. Specific areas of interest include autophagy and glucose transport.
Jacques Lux, Ph.D.
Helping treatment for childhood leukemia become more tolerable
Dr. Jacques Lux obtained his Ph.D. in chemistry at the University of Strasbourg under the guidance of Nobel Laureate Jean-Pierre Sauvage. He came to the U.S. to train in supramolecular chemistry at the University of California, San Diego’s Scripps Research Institute in La Jolla. Dr. Lux became a research scientist to develop and translate theranostics – a combination of therapy and diagnostics – for imaging and drug delivery.
He recently joined the Translational Research in Ultrasound Theranostics (TRUST) program at UT Southwestern in the Department of Radiology. His research focuses on inhibiting allergic reactions to the most common treatment utilized for pediatric patients with acute lymphoblastic leukemia, the most prevalent childhood cancer in the U.S.
Sara Piccirillo, Ph.D.
Stopping brain tumor cells migrating so tumors can be managed long-term
Dr. Sara G.M. Piccirillo received her Ph.D. in Translational and Molecular Medicine at the University of Milano-Bicocca. She was awarded a Marie Curie Intra-European Fellowship for Career Development and joined the University of Cambridge (U.K.) as Research Associate, and in 2016 completed her post-doctoral training.
Dr. Piccirillo’s expertise spans from molecular and cellular biology of brain tumors and neural stem cells to cancer genomics and animal models. Her research focuses on glioblastoma, a rare and aggressive type of brain cancer. Dr. Piccarillo’s study will combine an improved understanding of the mechanisms that glioblastoma cells use to migrate with drug screening to identify cell migration blockers that could be deployed in clinical trials.